Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179256 · ClinicalTrials.gov registry record · NA
Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT01179256 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 16 participants.
The verdict
NCT01179256, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Curcumin has antioxidant properties and in animal models has numerous molecular targets, many of which are intracellular, such as transcription factors AP-1 and NF. As such, it inhibits the secretion of both pro-inflammatory (TNF-, IL-6) and anti-inflammatory (IL-10) cytokines, possibly by inhibiting transcription factors such as nuclear factor-B (NF-B) and activator protein-1 (AP-1) (Wong et al).
Interventions
- DIETARY_SUPPLEMENT CURCUMIN
- OTHER no intervention other than stopping study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179256
The ClinicalTrials.gov registry entry for NCT01179256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CURCUMIN is the first listed.
NCT01179256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179256 about?
NCT01179256 is a clinical study titled "Effect of Supplemental Oral Curcumin in Patients With Atopic Asthma". Curcumin has antioxidant properties and in animal models has numerous molecular targets, many of which are intracellular, such as transcription factors AP-1 and NF. As such, it inhibits the secretion of both pro-inflammatory (TNF-, IL-6) and anti-inflammatory (IL-10) cytokines, possibly by inhibitin...
What is the current status of trial NCT01179256?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2009-03. Estimated completion is 2010-03.
What interventions are being tested in trial NCT01179256?
The interventions under investigation include: CURCUMIN (DIETARY_SUPPLEMENT), no intervention other than stopping study (OTHER).
Who is sponsoring clinical trial NCT01179256?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.